What are the advanced dermatologic manifestations and treatment guidelines for sexually transmitted infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Dermatologic Manifestations of Sexually Transmitted Infections: Advanced Overview and Guidelines

Primary Cutaneous STI Syndromes

The dermatologic manifestations of STIs encompass a spectrum of ulcerative, papulosquamous, vesiculobullous, and ectoparasitic presentations that require systematic algorithmic evaluation based on lesion morphology and distribution patterns.

Genital Ulcer Disease (GUD)

The differential diagnosis of genital ulceration follows a hierarchical approach based on pain characteristics and lymphadenopathy patterns:

Chancroid (Haemophilus ducreyi)

  • Clinical presentation: Painful, excavated ulcers with undermined borders and purulent base, accompanied by tender inguinal lymphadenopathy (pathognomonic when suppurative) 1
  • Diagnostic criteria: Probable diagnosis requires (1) painful genital ulcer(s), (2) negative darkfield examination or syphilis serology ≥7 days post-onset, and (3) negative HSV testing 1
  • Treatment regimen:
    • Azithromycin 1g PO single dose (preferred for compliance)
    • OR Ceftriaxone 250mg IM single dose
    • OR Ciprofloxacin 500mg PO BID × 3 days (contraindicated in pregnancy, lactation, age <18)
    • OR Erythromycin base 500mg PO QID × 7 days 1
  • Critical caveat: HIV-infected and uncircumcised patients demonstrate reduced treatment response; 10% coinfection rate with T. pallidum or HSV mandates concurrent testing 1

Syphilis (Treponema pallidum)

  • Primary syphilis: Painless, indurated chancre with clean base and non-tender regional lymphadenopathy
  • Secondary syphilis: Polymorphic exanthem including maculopapular eruption (classically involving palms/soles), condyloma lata, mucous patches, and moth-eaten alopecia
  • Treatment for early syphilis: Benzathine penicillin G 2.4 million units IM single dose 2
  • HIV considerations: Same treatment regimen, but CSF examination recommended before therapy with closer serologic follow-up at 1,2,3,6,9, and 12 months 2

Herpes Simplex Virus (HSV)

  • Clinical presentation: Grouped vesicles on erythematous base evolving to painful, shallow ulcerations; HSV-2 causes more frequent recurrences than HSV-1 genital infection 1
  • First episode treatment:
    • Acyclovir 400mg PO TID × 7-10 days (may extend if incomplete healing)
    • OR Acyclovir 200mg PO 5× daily × 7-10 days
    • OR Famciclovir 250mg PO TID × 7-10 days
    • OR Valacyclovir 1g PO BID × 7-10 days 1
  • Suppressive therapy: Reduces recurrence frequency by ≥75% in patients with ≥6 episodes/year; acyclovir safety documented for 6 years, valacyclovir/famciclovir for 1 year 1
  • Asymptomatic shedding: Occurs more frequently with HSV-2 and within first 12 months of infection; suppressive therapy reduces but does not eliminate transmission risk 1

Chlamydial Infections (Chlamydia trachomatis)

Routine screening of sexually active adolescents and women aged 20-24 with new/multiple partners is mandatory, as asymptomatic infection is common and can lead to PID, ectopic pregnancy, and infertility 1

Treatment Regimens

  • Azithromycin 1g PO single dose (preferred for compliance concerns)
  • OR Doxycycline 100mg PO BID × 7 days (equally efficacious, less expensive) 1
  • Alternative regimens: Erythromycin base 500mg PO QID × 7 days (less efficacious with GI side effects), OR Ofloxacin 300mg PO BID × 7 days 1
  • Critical management: Dispense medications on-site with directly observed first dose; abstain from intercourse × 7 days after single-dose therapy or until completion of 7-day regimen 1

Gonococcal Infections (Neisseria gonorrhoeae)

Uncomplicated Infections

  • Partner management: Evaluate partners with sexual contact within 30 days of symptom onset (symptomatic patients) or 60 days of diagnosis (asymptomatic patients) 2
  • Dual therapy: Presumptive chlamydial cotreatment is mandatory due to high coinfection rates 1

Disseminated Gonococcal Infection (DGI)

  • Clinical triad: Petechial/pustular acral skin lesions, asymmetric arthralgias, tenosynovitis
  • Treatment: Ceftriaxone 1g IM/IV q24h with hospitalization recommended initially; presumptive chlamydial cotreatment required 2

Gonococcal Conjunctivitis

  • Treatment: Ceftriaxone 1g IM single dose PLUS saline lavage of infected eye once 2

Proctocolitis and Proctitis

Acute proctitis in patients with recent receptive anal intercourse requires anoscopy and evaluation for HSV, N. gonorrhoeae, C. trachomatis, and T. pallidum 1

Empiric Treatment (pending laboratory results)

  • Ceftriaxone 125mg IM single dose PLUS Doxycycline 100mg PO BID × 7 days 1
  • Adjunctive measures: bed rest, scrotal elevation (for epididymitis), analgesics until fever/inflammation resolve 1

Human Papillomavirus (HPV) Infection

  • Visible genital warts: Typically caused by HPV types 6 or 11
  • High-grade anal squamous intraepithelial lesions (SIL): Increased incidence in HIV-infected men who have sex with men; management uncertain but ablation/surgical removal suggested 3
  • Screening controversy: Anal cytologic screening proposed for high-risk populations, but natural history of anal SIL not established and management strategies not clearly defined 3

Ectoparasitic Infections

Pediculosis Pubis

  • Treatment:
    • Permethrin 1% cream rinse applied to affected areas, wash off after 10 minutes (preferred for lower toxicity)
    • OR Lindane 1% shampoo × 4 minutes (contraindicated in pregnancy, lactation, age <2 years)
    • OR Pyrethrins with piperonyl butoxide, wash off after 10 minutes 1
  • Decontamination: Machine-wash/dry bedding and clothing on heat cycle or remove from body contact × 72 hours 1
  • Eyelash involvement: Occlusive ophthalmic ointment to eyelid margins BID × 10 days 1

Scabies (Sarcoptes scabiei)

  • Pathognomonic findings: Burrows in interdigital web spaces, wrists, axillae, genitalia; pruritus develops after sensitization period
  • Treatment: Partners within preceding month require treatment 1

Critical Management Principles

Universal Considerations

  1. Partner notification and treatment: Essential for all STIs; treat most recent partner even if outside standard time windows 2
  2. Sexual abstinence: Until patient and all partners complete therapy and are asymptomatic 1, 2
  3. HIV testing: Mandatory at STI diagnosis with repeat testing at 3 months if initially negative 1
  4. Pregnancy modifications: Avoid quinolones and tetracyclines; use cephalosporins or erythromycin alternatives 2
  5. HIV-infected patients: Generally receive same treatment regimens but require closer monitoring and may need extended therapy 1, 2

Diagnostic Pitfalls

  • Genital ulcer disease: At least 25% of cases have no laboratory-confirmed diagnosis after complete evaluation; empiric treatment for syphilis ± chancroid may be necessary in high-prevalence areas 1
  • Treatment failure indicators: Lack of clinical improvement within 3-7 days requires reassessment of diagnosis, coinfection, HIV status, compliance, and antimicrobial resistance 1
  • Follow-up timing: Reexamination at 3-7 days for chancroid, 1 week for pediculosis, with specific serologic follow-up schedules for syphilis in HIV-infected patients 1, 2

References

Related Questions

What steps should be taken after exposure to a sexually transmitted infection and receiving a positive test result?
What is the recommended retesting schedule for sexually transmitted infections (STIs) after completing treatment?
What is the appropriate management and treatment plan for a patient whose partner has a sexually transmitted infection (STI)?
Can you write a history and physical (H&P) for a 14‑year‑old female with a history of sexual assault who is presenting for a clinic follow‑up after treatment for a sexually transmitted infection and review of her testing results?
What tests should be ordered for a comprehensive sexually transmitted infection (STI) screen?
What is the appropriate management of acute pulmonary embolism?
Is a serum potassium of 5.3 mmol/L appropriate in a patient with diabetic ketoacidosis?
What is the recommended oral diclofenac dosing regimen for renal colic?
In an adult patient with acute renal colic and normal renal function, which oral NSAID provides the best balance of rapid pain relief and tolerability?
Should perindopril be discontinued in a patient with diabetic ketoacidosis and hyperkalaemia (serum potassium 5.3 mmol/L)?
What are the appropriate alternatives to acyclovir for treating herpes simplex virus infections, including oral, topical, and intravenous options?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.